Trupanion (NASDAQ:TRUP) CEO Sells $15,633.44 in Stock

Trupanion, Inc. (NASDAQ:TRUP) CEO Margaret Tooth sold 491 shares of the business’s stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $31.84, for a total transaction of $15,633.44. Following the completion of the transaction, the chief executive officer owned 186,952 shares of the company’s stock, valued at $5,952,551.68. The trade was a 0.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Margaret Tooth also recently made the following trade(s):

• On Tuesday, August 11th, Margaret Tooth sold 978 shares of Trupanion stock. The stock was sold at an average price of $29.05, for a total transaction of $28,410.90.

Trupanion Stock Performance

NASDAQ TRUP opened at $29.62 on Friday. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24. The firm has a market capitalization of $1.30 billion, a price-to-earnings ratio of 55.89, a P/E/G ratio of 2.00 and a beta of 1.39. The firm’s 50 day simple moving average is $27.00 and its 200 day simple moving average is $26.00. Trupanion, Inc. has a 1 year low of $21.16 and a 1 year high of $46.98.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.11 by $0.05. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. The business had revenue of $392.93 million for the quarter, compared to analysts’ expectations of $389.72 million. During the same period last year, the firm posted $0.22 earnings per share. The firm’s quarterly revenue was up 11.1% compared to the same quarter last year. As a group, research analysts expect that Trupanion, Inc. will post 0.63 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. Zacks Research lowered Trupanion from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 24th. Weiss Ratings raised Trupanion from a “hold (c-)” rating to a “hold (c)” rating in a research note on Wednesday. Piper Sandler cut Trupanion from an “overweight” rating to a “neutral” rating and decreased their target price for the company from $45.00 to $32.00 in a research report on Wednesday. Atlantic Securities set a $42.00 target price on Trupanion in a research report on Wednesday, July 15th. Finally, Stifel Nicolaus boosted their target price on Trupanion from $28.00 to $29.00 and gave the stock a “hold” rating in a research note on Thursday, August 20th. One research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $39.20.

Institutional Trading of Trupanion

Hedge funds have recently added to or reduced their stakes in the stock. Royal Bank of Canada increased its holdings in shares of Trupanion by 60.6% during the first quarter. Royal Bank of Canada now owns 29,763 shares of the financial services provider’s stock worth $1,109,000 after buying an additional 11,233 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Trupanion by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,603 shares of the financial services provider’s stock valued at $731,000 after acquiring an additional 858 shares during the last quarter. Millennium Management LLC lifted its stake in shares of Trupanion by 73.5% in the 1st quarter. Millennium Management LLC now owns 267,976 shares of the financial services provider’s stock valued at $9,987,000 after acquiring an additional 113,490 shares during the last quarter. Invesco Ltd. boosted its holdings in shares of Trupanion by 35.1% during the 2nd quarter. Invesco Ltd. now owns 187,749 shares of the financial services provider’s stock valued at $10,392,000 after acquiring an additional 48,781 shares in the last quarter. Finally, Gabelli Funds LLC acquired a new stake in shares of Trupanion during the 2nd quarter valued at $249,000.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.